NCT02283814View on ClinicalTrials.gov

A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Epilepsy
Interventions
DRUG

BIA 2-093

DRUG

Topamax

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02283814 - A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate | Biotech Hunter | Biotech Hunter